Innovative Cybersecurity Solutions Nova Leah offers cutting-edge, automated cybersecurity risk management platforms like SelectEvidence™ and the upcoming SelectEvaluateⓇ, providing a compelling value proposition for medical device manufacturers and healthcare providers seeking advanced security and compliance solutions.

Strong Industry Recognition The company's receipt of awards such as the 2019 High Potential Exporter of the Year and significant industry investments from Northwell Health and venture capital firms highlight its credibility and growth potential, making it an attractive partner for large healthcare organizations.

Growing Market Presence With recent product launches and US-based investment, Nova Leah is expanding its footprint in the healthcare cybersecurity market, presenting opportunities to engage with organizations prioritizing device security and third-party risk management.

Strategic Funding Backing Initial investments from Kernel Capital, Suir Valley Ventures, and Northwell Ventures demonstrate strong financial support, indicating resources for further product development and market outreach, ideal for sales prospects looking for innovative solutions.

Industry Sector Alignment Targeting a niche but vital segment of medical device security within the biomedical sector, Nova Leah aligns well with enterprise healthcare providers and device manufacturers focused on cybersecurity compliance, opening doors for strategic partnerships.